In 2021, the antibiotic susceptibility testing market generated US$ 2.82 billion in revenue. By 2028, the global market is projected to have grown at a compound annual growth rate of 5.2% and be valued US$ 4.05 billion. •Infectious diseases, prevailing at a high pace •Increasing rate and tenure of hospitalization •Growing significance of early diagnostics •Soaring …